HBW Advisory Services LLC Invests $216,000 in Danaher Co. (NYSE:DHR)

HBW Advisory Services LLC acquired a new position in shares of Danaher Co. (NYSE:DHR) during the second quarter, Holdings Channel reports. The institutional investor acquired 863 shares of the conglomerate’s stock, valued at approximately $216,000.

A number of other large investors have also modified their holdings of DHR. Cape Investment Advisory Inc. purchased a new stake in shares of Danaher during the fourth quarter worth $25,000. Tsfg LLC increased its holdings in Danaher by 733.3% in the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock valued at $25,000 after buying an additional 88 shares during the last quarter. Wetzel Investment Advisors Inc. purchased a new position in Danaher in the fourth quarter valued at $29,000. Redmont Wealth Advisors LLC purchased a new position in Danaher in the first quarter valued at $30,000. Finally, Rakuten Securities Inc. purchased a new position in Danaher in the fourth quarter valued at $36,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR traded down $0.48 during mid-day trading on Tuesday, hitting $268.84. 2,763,612 shares of the company’s stock were exchanged, compared to its average volume of 2,909,858. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $281.70. The firm has a market capitalization of $194.16 billion, a P/E ratio of 46.18, a P/E/G ratio of 4.62 and a beta of 0.83. The business’s 50 day moving average is $256.42 and its two-hundred day moving average is $251.43. The company has a current ratio of 1.43, a quick ratio of 1.04 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.15. Danaher had a net margin of 16.94% and a return on equity of 11.06%. The company had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.59 billion. During the same period last year, the company posted $2.05 earnings per share. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, equities analysts expect that Danaher Co. will post 7.59 earnings per share for the current year.

Insider Buying and Selling at Danaher

In other Danaher news, CFO Matthew Mcgrew sold 46,377 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $253.05, for a total value of $11,735,699.85. Following the completion of the transaction, the chief financial officer now directly owns 29,407 shares of the company’s stock, valued at $7,441,441.35. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, CFO Matthew Mcgrew sold 46,377 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The shares were sold at an average price of $253.05, for a total transaction of $11,735,699.85. Following the completion of the transaction, the chief financial officer now directly owns 29,407 shares of the company’s stock, valued at approximately $7,441,441.35. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Linda Filler sold 3,928 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $279.50, for a total transaction of $1,097,876.00. Following the transaction, the director now directly owns 41,149 shares of the company’s stock, valued at $11,501,145.50. The disclosure for this sale can be found here. Over the last three months, insiders sold 113,174 shares of company stock valued at $29,775,644. Corporate insiders own 11.10% of the company’s stock.

Analysts Set New Price Targets

DHR has been the topic of several recent analyst reports. Bank of America increased their target price on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a report on Wednesday, July 24th. Royal Bank of Canada increased their target price on Danaher from $297.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Robert W. Baird increased their target price on Danaher from $271.00 to $278.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and upped their price objective for the company from $250.00 to $280.00 in a research note on Wednesday, April 17th. Finally, Jefferies Financial Group assumed coverage on shares of Danaher in a research note on Monday, June 3rd. They issued a “buy” rating and a $295.00 price objective for the company. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $276.88.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.